---

Pfizer CentreOne is a CDMO backed by Pfizer resources and a supplier of specialty APIs and intermediates. In essence, CentreOne is a self-contained organization – with its own dedicated teams – that sits inside Pfizer.

Pfizer has been providing contract manufacturing services for more than 45 years, but the name ‘Pfizer CentreOne’ was only introduced in 2016, following Pfizer’s acquisition of Hospira. Hospira’s One 2 One sterile injectables CMO and Pfizer’s CentreSource API business were merged to create Pfizer CentreOne. The company has expertise in small molecules, biopharmaceuticals, oral solids, sterile injectables, and more, spanning development services, clinical and commercial manufacturing, and lifecycle management.

Andrew Moore, General Manager of Pfizer CentreOne, says: “This recognition means a great deal to our team at Pfizer CentreOne. To be acknowledged as the CDMO of the year, among our industry peers, is truly significant. Our people work every day to live up to the confidence our customers place in us and be the partner they deserve. We are building something that is altogether different in the CDMO space and a win like this is clear evidence that we’re achieving our goals. It makes all of us proud and determined to continue to deliver for our customers and, ultimately, for patients.”

Key facts
 

Global headquarters: New York, USA

Revenue in 2021: $1.7 billion
 

Honorable mention: Lonza